0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Colorectal Cancer (CRC) -Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-119
Home | Market Reports | Health | Health Conditions | Cancer
Colorectal Cancer Epidemiology Forecast to 2028

Colorectal Cancer (CRC) -Epidemiology Forecast to 2028

Code: DELV-Epid-119
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Colorectal Cancer (CRC)  - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Colorectal Cancer (CRC)  epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

 Study Period: 2016-2028

Colorectal Cancer (CRC)  Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Colorectal Cancer (CRC)  in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Colorectal Cancer (CRC)  outlook. It also includes the explanation of changing trends of epidemiology outlining the Colorectal Cancer (CRC)  scenario.

Colorectal Cancer (CRC)  Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Colorectal Cancer (CRC)  thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Colorectal Cancer (CRC)  explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Colorectal Cancer (CRC)  Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
10 Year Forecast
• 7MM Coverage
• Total Cases in Colorectal Cancer (CRC)

Key assessments
• Patient Segmentation in Colorectal Cancer (CRC)
• Colorectal Cancer (CRC)  Risk & Burden
• Factors driving growth in a specific Colorectal Cancer (CRC)  patient population

1.Report Introduction
2. Colorectal Cancer (CRC) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Colorectal Cancer (CRC) in 2016
2.2. Patient Share Distribution of Colorectal Cancer (CRC) in 2028
3. Disease Background and Overview: Colorectal Cancer (CRC)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Colorectal Cancer (CRC) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Colorectal Cancer (CRC) in 7MM – By Countries
5. Epidemiology of Colorectal Cancer (CRC) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Colorectal Cancer (CRC)
5.1.3. Sub-Type Specific cases of the Colorectal Cancer (CRC) *
5.1.4. Sex- Specific Cases of the Colorectal Cancer (CRC)*
5.1.5. Diagnosed Cases of the Colorectal Cancer (CRC)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Colorectal Cancer (CRC)
5.4.3. Sub-Type Specific cases of the Colorectal Cancer (CRC)*
5.4.4. Sex- Specific Cases of the Colorectal Cancer (CRC)*
5.4.5. Diagnosed Cases of the Colorectal Cancer (CRC)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Colorectal Cancer (CRC)
5.5.3. Sub-Type Specific cases of the Colorectal Cancer (CRC)*
5.5.4. Sex- Specific Cases of the Colorectal Cancer (CRC)*
5.5.5. Diagnosed Cases of the Colorectal Cancer (CRC)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Colorectal Cancer (CRC)
5.6.3. Sub-Type Specific cases of the Colorectal Cancer (CRC)*
5.6.4. Sex- Specific Cases of the Colorectal Cancer (CRC)*
5.6.5. Diagnosed Cases of the Colorectal Cancer (CRC)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Colorectal Cancer (CRC)
5.7.3. Sub-Type Specific cases of the Colorectal Cancer (CRC)*
5.7.4. Sex- Specific Cases of the Colorectal Cancer (CRC)*
5.7.5. Diagnosed Cases of the Colorectal Cancer (CRC)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Colorectal Cancer (CRC)
5.8.3. Sub-Type Specific cases of the Colorectal Cancer (CRC)*
5.8.4. Sex- Specific Cases of the Colorectal Cancer (CRC)*
5.8.5. Diagnosed Cases of the Colorectal Cancer (CRC)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Colorectal Cancer (CRC)
5.9.3. Sub-Type Specific cases of the Colorectal Cancer (CRC)*
5.9.4. Sex- Specific Cases of the Colorectal Cancer (CRC)*
5.9.5. Diagnosed Cases of the Colorectal Cancer (CRC)
6. Unmet Needs of the Colorectal Cancer (CRC)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Table:

Table 1: Total Prevalent/Incident Cases of the Colorectal Cancer (CRC) in 7MM
Table 2: Total Prevalent/Incident Cases of the Colorectal Cancer (CRC) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Colorectal Cancer (CRC) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Colorectal Cancer (CRC) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Colorectal Cancer (CRC) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Colorectal Cancer (CRC) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Colorectal Cancer (CRC) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Colorectal Cancer (CRC) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Colorectal Cancer (CRC) in France (2016-2028) *
Table 14: Diagnosed Cases of the Colorectal Cancer (CRC) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Colorectal Cancer (CRC) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Colorectal Cancer (CRC) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Colorectal Cancer (CRC) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Colorectal Cancer (CRC) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Colorectal Cancer (CRC) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Colorectal Cancer (CRC) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Colorectal Cancer (CRC) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Colorectal Cancer (CRC) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Colorectal Cancer (CRC) in Japan (2016-2028)

List of Figure: 

Figure 1: Total Prevalent/Incident Cases of the Colorectal Cancer (CRC) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Colorectal Cancer (CRC) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Colorectal Cancer (CRC) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Colorectal Cancer (CRC) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Colorectal Cancer (CRC) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Colorectal Cancer (CRC) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Colorectal Cancer (CRC) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Colorectal Cancer (CRC) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Colorectal Cancer (CRC) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Colorectal Cancer (CRC) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Colorectal Cancer (CRC) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Colorectal Cancer (CRC) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Colorectal Cancer (CRC) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Colorectal Cancer (CRC) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Colorectal Cancer (CRC) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Colorectal Cancer (CRC) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Colorectal Cancer (CRC) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Colorectal Cancer (CRC) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Colorectal Cancer (CRC) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Colorectal Cancer (CRC) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Colorectal Cancer (CRC) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

China Anti inflammatory Therapeutics Market Report Forecast 2021 2027
China Anti-inflammatory Therapeutics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-4J2573
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Anti tumor Drug Market Report Forecast 2021 2027
China Anti-tumor Drug Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-27N2168
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Asparaginase Market Report Forecast 2021 2027
China Asparaginase Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-9I393
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and United States Radiation Oncology Market Size Status and Forecast 2021 2027
Global and United States Radiation Oncology Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18B3286
Mon Sep 27 00:00:00 UTC 2021

Add to Cart